Navalign LLC
TMO icon

Navalign LLC’s Thermo Fisher Scientific TMO Stock Holding History

Navalign LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.63M Sell
2,410
-32
-1% -$19K 0.37% 48
2026
Q2 		$1.22M Buy
2,442
+57
+2% +$27.4K 0.29% 60
2026
Q1 		$1.17M Buy
2,385
+83
+4% +$45K 0.3% 60
2025
Q4 		$1.33M Buy
2,302
+85
+4% +$48.1K 0.33% 50
2025
Q3 		$1.08M Buy
2,217
+54
+2% +$25.1K 0.28% 55
2025
Q2 		$877K Buy
2,163
+21
+1% +$8.78K 0.24% 69
2025
Q1 		$1.07M Buy
2,142
+48
+2% +$26K 0.3% 56
2024
Q4 		$1.09M Buy
2,094
+31
+2% +$17K 0.32% 54
2024
Q3 		$1.28M Buy
2,063
+32
+2% +$18.9K 0.38% 48
2024
Q2 		$1.12M Buy
2,031
+143
+8% +$81.9K 0.35% 50
2024
Q1 		$1.1M Buy
1,888
+149
+9% +$83.6K 0.36% 51
2023
Q4 		$923K Sell
1,739
-212
-11% -$103K 0.32% 61
2023
Q3 		$987K Buy
1,951
+51
+3% +$27.2K 0.37% 54
2023
Q2 		$991K Sell
1,900
-41
-2% -$22.1K 0.4% 45
2023
Q1 		$1.12M Buy
1,941
+77
+4% +$43.4K 0.47% 38
2022
Q4 		$1.03M Sell
1,864
-29
-2% -$15.4K 0.42% 47
2022
Q3 		$960K Buy
1,893
+35
+2% +$19.6K 0.43% 41
2022
Q2 		$1.01M Sell
1,858
-20
-1% -$11K 0.44% 41
2022
Q1 		$977K Sell
1,878
-27
-1% -$15.5K 0.41% 48
2021
Q4 		$1.27M Sell
1,905
-54
-3% -$33.7K 0.51% 37
2021
Q3 		$1.12M Sell
1,959
-460
-19% -$252K 0.47% 44
2021
Q2 		$1.22M Buy
2,419
+29
+1% +$13.7K 0.52% 42
2021
Q1 		$1.09M Buy
+2,390
New +$1.14M 0.48% 44

Other funds holding TMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Navalign LLC's TMO Position: Q3 2026 in Review

Navalign LLC reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q3 2026, selling an estimated $19K and leaving 2,410 shares worth $1.63M. The position accounts for 0.37% of the portfolio, ranked #48.

Navalign LLC first reported a position in TMO in Q1 2021 and has held it in 23 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Navalign LLC held 2,410 shares of Thermo Fisher Scientific worth $1.63M as of Q3 2026.
  • Navalign LLC sold 32 Thermo Fisher Scientific shares in Q3 2026, an estimated $19K.
  • Thermo Fisher Scientific made up 0.37% of Navalign LLC's portfolio in Q3 2026, its #48 holding.
  • Navalign LLC first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 23 quarters since.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Navalign LLC's 13F filing for Q3 2026, filed 9 Nov 2026.